C21 shows promise against COVID-19 where other drugs have failed
Top line data on the ATTRACT study
Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients
Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic
Interview with Ella Radvogin, Clinical Psychologist at Alex Therapeutics